Paxlovid may help prevent hospitalization, death in COVID outpatients CIDRAP

Two new studies, one from the United States and one from Canada, suggest that the oral antiviral drug Paxlovid (nirmatrelvir-ritonavir) is effective in lowering the odds of hospitalization or death from the SARS-CoV-2 Omicron subvariant.

...

Political leaning influences doctors' beliefs about COVID treatments, study finds CIDRAP

Left or right political leaning in the United States predicts both physician and patient beliefs about COVID-19 treatments, with the two groups perceiving information differently, according to a study to be published this week in the Proceedings of the National Academy of Sciences (PNAS).

Family caregivers of people with long COVID bear an extra burden

...

With unpredictable symptoms that can wax and wane mysteriously, long COVID also requires exceptionally good record-keeping, in order to provide doctors with new clues. But because the disease often causes fatigue and brain fog, some patients can't keep track for themselves. They rely on friends or family for help.

"The family caregiver becomes the care manager, advocating and managing the system," the late John Schall, former CEO of the Caregiver Action Network, an education and advocacy nonprofit, told us last year. "And you're doing it by guesswork. Nobody tells you what to look for."

...